October 09, 2026

Oral Toxicities With Antibody-Drug Conjugates: What Physicians Should Know

Antibody-drug conjugates (ADCs) have become an increasingly important part of treatment for several advanced cancers, pairing a tumor-targeting antibody with a cytotoxic payload.

Baptist Health South Florida

October 07, 2026

MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma

Statistical significance in overall survival benefit was achieved in patients aged 65 and under.

Roswell Park Comprehensive Cancer Center

October 02, 2026

DCIS and Active Monitoring: When Immediate Surgery May Not Be the Only Conversation

The management of ductal carcinoma in situ (DCIS) is entering a period of increasing treatment de-escalation

Baptist Health South Florida

September 30, 2026

Brian Wolpin Celebrates FDA Approval of Daraxonrasib in Pancreatic Cancer as the Future of the Field

he U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.

Dana-Farber

September 29, 2026

Thyroid Cancer: What Are the Latest Advances in Treatment?

Thyroid cancer is usually a highly treatable malignancy with overall five-year survival rates over 98%. Many patients with thyroid cancer go on to live for several decades after their disease is cured. 

Keck Medicine of USC

September 29, 2026

Prostate Cancer Care: Advances in Risk Stratification, Imaging and Treatment

The management of prostate cancer continues to move toward increasingly individualized care, with advances in imaging, biopsy techniques, molecular imaging and minimally invasive treatment helping physicians more precisely identify clinically significant disease and tailor therapy to the individual patient.

Baptist Health South Florida

September 24, 2026

Precision Focal Therapy for Localized Prostate Cancer: Integrating PSMA PET, HIFU and AI-Assisted Planning

For patients with localized prostate cancer, treatment selection increasingly involves more than choosing between radical prostatectomy and radiation therapy.

Baptist Health South Florida

September 24, 2026

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

Baptist Health South Florida

September 23, 2026

Matthew David Hall, M.D., MBA, Installed as Endowed Chair in Pediatric Oncology at Baptist Health Herbert Wertheim Cancer Institute

Matthew D. Hall, M.D., MBA, lead pediatric radiation oncologist at Baptist Health Herbert Wertheim Cancer Institute, part of Baptist Health Cancer Care, was formally installed as the Endowed Chair in Pediatric Radiation Oncology.

Baptist Health South Florida

September 23, 2026

Aurelio B. Castrellon, M.D., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist

Board-certified medical oncologist Aurelio B. Castrellon, M.D., has joined the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health in Boynton Beach.

Baptist Health South Florida